Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sensor Detects Lactate Levels in Individual Cancer Cells

By LabMedica International staff writers
Posted on 25 Mar 2013
A team of scientists devised a molecular sensor that detects levels of lactate in individual cells. More...
A high rate of lactate production indicates that cancer is present, via diagnostics such as positron emission tomography (PET) scans, and may offer an opportunity for novel cancer therapies.

The scientists used a bacterial transcription factor—a protein that binds to specific DNA sequences to control the flow of genetic information from DNA to mRNA—as a means to produce and insert the lactate sensor. They turned on the sensor in three cell types: normal brain cells, tumor brain cells, and human embryonic cells. The sensor was able to quantify very low concentrations of lactate, providing good sensitivity and range of detection. Sugars are broken up by cancer cells and produce the metabolic acid lactate at a much greater rate than normal cells. The tumor cells produced lactate three to five times faster than the nontumor cells.

“The high rate of lactate production in the cancer cell is the hallmark of cancer metabolism,” remarked Prof. Frommer. “This result paves the way for understanding the nuances of cancer metabolism in different types of cancer and for developing new techniques for combating this scourge.”

Chilean researchers from the Centro de Estudios Científicos (CECs; Valdivia, Chile) with the collaboration of Carnegie’s Institute of Washington (Washington DC, USA) Prof. Wolf Frommer devised the molecular sensor that detects levels of lactate in individual cells. Prior to this advance, no other measurement method could noninvasively detect lactate in real time at the single-cell level. The work, published in the February 26, 2013, edition of the open access journal PLOS ONE, is a boon to understanding how different types of cells go awry when cancer hits.

The biosensors also might be able to solve an old controversy. While some studies have suggested the glucose provides fuel for the brain, recent research has provided evidence that lactate feeds energy metabolism in neurons. Oxidation of lactate can be used to produce large amounts of adenosine tri-phosphate (ATP), the coenzyme that carries energy in cells. The Barros and Frommer teams are excited about the possibility of solving this enigma with the use of their new sensors, together with previously developed glucose sensors.

“Over the last decade, the [Wolf] Frommer lab at Carnegie’s Institution of has pioneered the use of Förster resonance energy transfer, or FRET, sensors to measure the concentration and flow of sugars in individual cells with a simple fluorescent color change. This has started to revolutionize the field of cell metabolism,” explained CECs researcher Alejandro San Martin, lead author of the article. “Using the same underlying physical principle and inspired by the sugar sensors, we have now invented a new type of sensor based on a transcriptional factor. A molecule that normally helps bacteria to adapt to its environment has now been tricked into measuring lactate for us.”

Related Links:
Centro de Estudios Científicos
Carnegie’s Institute of Washington


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.